SENIOR CONVERTIBLE NOTE DUE March 14, 2025Allarity Therapeutics, Inc. • March 15th, 2024 • Pharmaceutical preparations • Delaware
THIS SENIOR CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Senior Convertible Notes of Allarity Therapeutics, Inc., a Delaware corporation (the “Company”), having its principal place of business at 24 School Street, 2nd Floor, Boston, MA 02108, designated as its Senior Convertible Note due March 14, 2025 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
